Summary:
- Calumet Specialty Products Partners, L.P. (CLMT, Financial) reports a Q1 GAAP EPS of -$1.87 with slight revenue decline.
- Analyst target prices suggest a potential upside of 72.70% from the current stock price.
- Consensus recommendation indicates an "Outperform" status with an average brokerage rating of 2.5.
First-Quarter Financial Highlights
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) recently declared its first-quarter financial results, showing a GAAP EPS of -$1.87. The company experienced a minor revenue downturn of 0.6% year-over-year, bringing the total revenue to $993.9 million. Analysts have provided mixed signals, highlighted by UBS’s upgrade and TD Cowen’s downgrade, reflecting different risk outlooks.
Analysts' Projections and Price Targets
According to the forecasts from four analysts, the average price target for Calumet Inc (CLMT, Financial) stands at $20.50, with expectations ranging from a high of $33.00 to a low of $12.00. This implies a promising upside potential of 72.70% from the current trading price of $11.87. For a more in-depth view of estimates, please visit the Calumet Inc (CLMT) Forecast page.
Brokerage Recommendations
The consensus from six brokerage firms rates Calumet Inc (CLMT, Financial) with an average recommendation of 2.5, which indicates a status of "Outperform." The brokerage rating scale ranges from 1, representing a Strong Buy, to 5, indicating a Sell.
GF Value Estimation
According to GuruFocus estimates, the GF Value for Calumet Inc (CLMT, Financial) is projected to be $13.47 within one year. This suggests a potential upside of 13.48% from its current valuation of $11.87. The GF Value represents GuruFocus' calculated fair value of the stock, based on historical trading multiples, previous business growth, and future performance expectations. For more comprehensive data, visit the Calumet Inc (CLMT) Summary page.
